MeiraGTx Holdings plc Investment Income, Interest
MeiraGTx Holdings plc (MGTX) reported Investment Income, Interest of $706.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- MeiraGTx Holdings plc investment income, interest for the quarter ending 2026-06-30 was $706.00K, a 73.04% increase year-over-year.
- MeiraGTx Holdings plc investment income, interest for the quarter ending 2026-03-31 was $189.00K, a 80.54% decline year-over-year.
- MeiraGTx Holdings plc investment income, interest for the quarter ending 2025-12-31 was $278.00K, a 73.06% decline year-over-year.
- MeiraGTx Holdings plc investment income, interest for the quarter ending 2025-09-30 was $161.00K, a 86.46% decline year-over-year.
- MeiraGTx Holdings plc investment income, interest for fiscal 2025 was $1.82M, a 56.14% decline from fiscal 2024.
- MeiraGTx Holdings plc investment income, interest for fiscal 2024 was $4.14M, a 82.44% increase from fiscal 2023.
- MeiraGTx Holdings plc investment income, interest for fiscal 2023 was $2.27M, a 192.41% increase from fiscal 2022.
- MeiraGTx Holdings plc investment income, interest for fiscal 2022 was $777.00K, a 266.51% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $706.00K 10-Q · filed 2026-08-13 | $895.00K 10-Q · filed 2026-08-13 | $1.17M derived: sum of 3 quarters · filed 2026-08-13 | $1.33M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $189.00K 10-Q · filed 2026-05-14 | $467.00K derived: sum of 2 quarters · filed 2026-05-14 | $628.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.04M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $439.00K derived: sum of 2 quarters · filed 2026-03-30 | $847.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.82M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $161.00K 10-Q · filed 2025-11-13 | $569.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.54M 10-Q · filed 2025-11-13 | $2.57M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $408.00K 10-Q · filed 2026-08-13 | $1.38M 10-Q · filed 2026-08-13 | $2.41M derived: sum of 3 quarters · filed 2026-08-13 | $3.60M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $971.00K 10-Q · filed 2026-05-14 | $2.00M derived: sum of 2 quarters · filed 2026-05-14 | $3.19M derived: sum of 3 quarters · filed 2026-05-14 | $4.02M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.22M derived: sum of 2 quarters · filed 2026-03-30 | $3.05M derived: sum of 3 quarters · filed 2026-03-30 | $4.14M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $1.19M 10-Q · filed 2025-11-13 | $2.02M derived: sum of 2 quarters · filed 2025-11-13 | $3.11M 10-Q · filed 2025-11-13 | $3.66M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $827.00K 10-Q · filed 2025-08-14 | $1.92M 10-Q · filed 2025-08-14 | $2.47M derived: sum of 3 quarters · filed 2025-08-14 | $3.00M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-13 | $1.65M derived: sum of 2 quarters · filed 2025-05-13 | $2.17M derived: sum of 3 quarters · filed 2025-05-13 | $2.82M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $1.07M derived: sum of 2 quarters · filed 2025-03-13 | $1.73M derived: sum of 3 quarters · filed 2025-03-13 | $2.27M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | $523.00K 10-Q · filed 2024-11-13 | $1.18M derived: sum of 2 quarters · filed 2024-11-13 | $1.72M 10-Q · filed 2024-11-13 | $2.15M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $655.00K 10-Q · filed 2024-08-12 | $1.20M 10-Q · filed 2024-08-12 | $1.63M derived: sum of 3 quarters · filed 2024-08-12 | $1.92M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $545.00K 10-Q · filed 2024-05-09 | $977.00K derived: sum of 2 quarters · filed 2024-05-09 | $1.26M derived: sum of 3 quarters · filed 2024-05-09 | $1.31M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $432.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $720.00K derived: sum of 2 quarters · filed 2024-03-15 | $761.00K derived: sum of 3 quarters · filed 2024-03-15 | $777.00K 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | $288.00K 10-Q · filed 2023-11-14 | $329.00K derived: sum of 2 quarters · filed 2023-11-14 | $345.00K 10-Q · filed 2023-11-14 | $369.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $41.00K 10-Q · filed 2023-08-10 | $57.00K 10-Q · filed 2023-08-10 | $81.00K derived: sum of 3 quarters · filed 2023-08-10 | $114.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $16.00K 10-Q · filed 2023-05-11 | $40.00K derived: sum of 2 quarters · filed 2023-05-11 | $73.00K derived: sum of 3 quarters · filed 2023-05-11 | $140.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $57.00K derived: sum of 2 quarters · filed 2023-03-14 | $124.00K derived: sum of 3 quarters · filed 2023-03-14 | $212.00K 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $33.00K 10-Q · filed 2022-11-10 | $32.00K 10-Q · filed 2021-11-10 | $100.00K derived: sum of 2 quarters · filed 2022-11-10 | $188.00K 10-Q · filed 2022-11-10 | $323.00K derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $67.00K 10-Q · filed 2022-08-11 | $156.00K 10-Q · filed 2022-08-11 | $290.00K derived: sum of 3 quarters · filed 2022-08-11 | $448.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $89.00K 10-Q · filed 2022-05-12 | $223.00K derived: sum of 2 quarters · filed 2022-05-12 | $381.00K derived: sum of 3 quarters · filed 2022-05-12 | $574.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $292.00K derived: sum of 2 quarters · filed 2022-03-10 | $485.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.27M 10-K · filed 2022-03-10 | $1.28M 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $158.00K 10-Q · filed 2021-11-10 | $158.35K 10-Q · filed 2020-11-05 | $351.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.14M 10-Q · filed 2021-11-10 | $1.14M 10-Q · filed 2020-11-05 | $1.47M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $193.00K 10-Q · filed 2021-08-11 | $193.60K 10-Q · filed 2020-08-06 | $983.00K 10-Q · filed 2021-08-11 | $982.98K 10-Q · filed 2020-08-06 | $1.31M derived: sum of 3 quarters · filed 2021-08-11 | $1.31M derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | $789.00K 10-Q · filed 2021-05-11 | $789.37K 10-Q · filed 2020-05-07 | $1.12M derived: sum of 2 quarters · filed 2021-05-11 | $1.12M derived: sum of 3 quarters · filed 2021-05-11 | $1.16M derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $329.92K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $330.88K derived: sum of 2 quarters · filed 2021-03-11 | $370.60K derived: sum of 3 quarters · filed 2021-03-11 | $370.60K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $959.00 10-Q · filed 2020-11-05 | $40.69K derived: sum of 2 quarters · filed 2020-11-05 | $40.69K 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $39.73K 10-Q · filed 2020-08-06 | $39.73K 10-Q · filed 2020-08-06 | ||||||
| 2018-12-31 | $2.48K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $2.75K derived: sum of 2 quarters · filed 2020-03-11 | $28.10K derived: sum of 3 quarters · filed 2020-03-11 | $53.41K 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $264.00 10-Q · filed 2019-11-07 | $25.62K derived: sum of 2 quarters · filed 2019-11-07 | $50.93K 10-Q · filed 2019-11-07 | $55.70K derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $25.35K 10-Q · filed 2019-08-07 | $50.66K 10-Q · filed 2019-08-07 | $55.44K derived: sum of 3 quarters · filed 2019-08-07 | $58.35K derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $25.31K 10-Q · filed 2019-05-14 | $30.09K derived: sum of 2 quarters · filed 2019-05-14 | $33.00K derived: sum of 3 quarters · filed 2019-05-14 | $40.99K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $7.69K derived: sum of 2 quarters · filed 2019-03-26 | $15.68K derived: sum of 3 quarters · filed 2019-03-26 | $26.07K 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | $2.92K 10-Q · filed 2018-11-08 | $10.91K derived: sum of 2 quarters · filed 2018-11-08 | $21.30K 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | $7.99K 10-Q · filed 2018-08-08 | $18.38K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |